Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
EBITDA grew by 11% on a YoY basis to Rs. 296 crore due to improved performance in CDMO Sterile Injectables, CRDMO and Generics
Aims to become India’s leading cancer testing company
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Subscribe To Our Newsletter & Stay Updated
